GlobeNewswire

Gainsight(TM) Unveils New Solution to Drive Customer Success Through Professional Services

Dela

Gainsight for Services Success Enables Shift in Service Strategy from Hours to Outcomes

LAS VEGAS, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Gainsight(TM), the Customer Success company, today unveiled a new solution on its Customer Success software platform called Gainsight for Services Success, designed exclusively for professional services teams. Now, for the first time, services teams have access to a technology platform that will enable them to drive a seamless customer journey from the handoff from sales to the realization of specific business outcomes.

Over the past 10 years, with the rise of the subscription business model, companies have increasingly begun to offer their customers new services as a way of providing value on top of their products or to drive entirely new revenue streams. According to Gartner, by 2020 more than 80% of software vendors will change their primary business model from traditional license and maintenance to subscription. 

To make this shift successfully, businesses need to engage with their customers in an entirely new manner. Customers of subscription-based services are intensely focused on time-to-value as well as the achievement of specific business outcomes. As a result, the traditional approach of services organizations, which is focused on project success (time and budget), isn't enough to succeed in the subscription economy. Therefore, Gainsight is extending its Customer Success platform with Gainsight for Services Success to enable professional services organizations to quickly and efficiently onboard clients at scale, as well as measure service engagement results based on business outcomes. As a result, Gainsight for Services Success can complement an existing Professional Services Automation (PSA) solution investment which is focused on project success but missing critical customer context.

"While professional services teams have long been at the forefront of customer engagement, their tools have been very internally focused on the management and control of their project-based business," said Nick Mehta, CEO of Gainsight.  "As companies shift to subscription-based offerings, they need a tool that bridges the gap between managing the internal operations of their services business and managing the higher expectations of today's customers. With our focus on Customer Success, Gainsight is uniquely positioned to help professional services teams thrive in the subscription economy."

Gainsight for Services Success Solution Highlights

  • Success Plans:  Ensure smooth handoffs from sales by capturing the customer's desired business outcomes during the sales cycle, and stay aligned with those goals throughout the customer journey
  • Customer Journey Orchestrator:  Create seamless engagement across the entire customer journey using a mix of human and digital touchpoints
  • Service Performance Surveys:  Capture customer sentiment through a turnkey survey program to get the pulse on projects, from start to post-completion
  • Service Scorecards:  Tie project goals to tangible metrics to measure the impact of a project with sophisticated scorecards
  • Project 360:  Centralize project information, customer data, and intelligent workflow to maintain a comprehensive picture of the customer and proactively address project risk and escalations
  • Proactive Calls-to-Action:  Manage project risk or capitalize on a sales opportunity with automated alerts triggered by trends in data

"Giving our Onboarding Team access to Gainsight has allowed us to improve our enterprise Onboarding CSAT from 8.25 to 9.15 (out of 10) over the past 18 months," said Domenico Batteate, Program Manager, New Customer Experience at Adobe. "With Gainsight, we can streamline the onboarding experience, consistently measure the impact and ensure our customers are receiving the outcomes they purchased Adobe for."

"Gainsight has enabled us to streamline our onboarding program without compromising the experience and outcomes we can deliver," said Bharath Devanathan, Chief Customer Officer at Belong. "Giving our onboarding team the tools to contribute to the initial customer journey ensures a strong foundation for long-term customer success."

Founded in 2011, Gainsight's mission has been to deliver the technology, expertise and community companies need to turn their customers into their best growth engine. As the shift from one-time sales to recurring revenue accelerates, the only way to to drive profitable growth is to improve customer retention and expansion. According to the investment bank Pacific Crest's 2015 survey, it is 6x-8x cheaper to retain or up-sell an existing client than it is to get a new one.  With a suite of offerings designed to unify customer data, provide strategic insight into your customer portfolio and drive integrated human and automated action, Gainsight is widely considered the leading provider of customer success solutions.  

For More Information:

About Gainsight(TM)
Gainsight(TM), the Customer Success company, helps businesses grow faster by reducing churn, increasing upsell, and driving customer advocacy. Gainsight's product helps you touch customers effectively, track customer health consistently and transform the way your company orients around the customer. Gainsight provides a 360° view of customers and drives retention across Customer Success, sales, marketing, executive and product management. Learn how leading companies like Adobe, Box, Cisco, DocuSign, HPE, Marketo and Workday use Gainsight to help their customers succeed at www.gainsight.com.

Connect with Gainsight:
Blog: www.gainsight.com/blog 
Twitter: www.twitter.com/GainsightHQ 
Facebook: www.facebook.com/Gainsight

Contact

Mike Moeller
Aircover Communications
408-439-4169
mike.moeller@aircoverpr.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Gainsight via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum